Form 4 Tracker
Bicara Therapeutics Inc.
BCAX

43 insider filings · Latest: Aug 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 3 9:11 PMRaben David
Proposed Sale
200$18.45$3.7K

View →

Mar 3, 2026Mar 3 9:09 PMCohlhepp Ryan
Proposed Sale
17,392$18.16$315.9K

View →

Feb 26, 2026Mar 2 9:22 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
300,000$16.00$4.8M4,603,418(I)

View →

Feb 25, 2026Feb 27 9:13 PMRyan CohlheppDirector, President and COO
Sale
3,631$18.04$65.5K209,641(D)

View →

Feb 25, 2026Feb 25 9:03 PMCohlhepp Ryan
Proposed Sale
3,631$18.04$65.5K

View →

Jan 22, 2026Jan 26 9:34 PMRyan CohlheppDirector, President and COO
Sale
3,828$18.10$69.3K210,164(D)

View →

Jan 22, 2026Jan 26 9:33 PMIvan HyepChief Financial Officer
Sale
1,882$18.15$34.2K145,355(D)

View →

Jan 22, 2026Jan 22 9:07 PMCohlhepp Ryan
Proposed Sale
3,828$16.97$65.0K

View →

Jan 22, 2026Jan 22 9:03 PMHyep Ivan
Proposed Sale
1,882$18.15$34.2K

View →

Jan 15, 2026Jan 20 9:52 PMRyan CohlheppDirector, President and COO
Sale
149$18.02$2.7K213,992(D)

View →

Jan 15, 2026Jan 15 9:03 PMCohlhepp Ryan
Proposed Sale
149$18.02$2.7K

View →

Dec 22, 2025Dec 22 9:08 PMHyep Ivan
Proposed Sale
9,200$17.87$164.4K

View →

Dec 15, 2025Dec 15 9:04 PMCohlhepp Ryan
Proposed Sale
12,500$18.70$233.8K

View →

Nov 25, 2025Nov 25 9:29 PMRaben David
Proposed Sale
5,500$18.84$103.6K

View →

Nov 24, 2025Nov 24 9:24 PMMazumdar Claire
Proposed Sale
41,163$18.86$776.4K

View →

Nov 24, 2025Nov 24 9:10 PMHyep Ivan
Proposed Sale
17,795$18.55$330.1K

View →

Nov 24, 2025Nov 24 9:09 PMRaben David
Proposed Sale
5,500$18.45$101.5K

View →

Nov 21, 2025Nov 21 9:33 PMHyep Ivan
Proposed Sale
605$18.15$11.0K

View →

Nov 21, 2025Nov 21 9:32 PMCohlhepp Ryan
Proposed Sale
12,500$18.05$225.6K

View →

Oct 16, 2025Oct 16 8:13 PMMazumdar Claire
Proposed Sale
24,103$18.83$453.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 12, 2026Aug 14 8:54 PMJennifer LarsonChief Financial Officer
Grant/Award
285,000$24.63285,000(D)

View →

Aug 10, 2026Aug 12 8:19 PMIvan HyepChief Financial Officer
Option Exercise
12,500$3.7926,336(D)

View →

Aug 10, 2026Aug 12 8:19 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
10,000$3.79110,546(D)

View →

Aug 10, 2026Aug 12 8:19 PMRyan CohlheppDirector, President and COO
Option Exercise
18,750$3.7951,752(D)

View →

Jul 28, 2026Jul 29 8:18 PMJeremy BenderDirector
Grant/Award
38,950$26.8838,950(D)

View →

Jul 28, 2026Jul 29 8:18 PMChristy J. OligerDirector
Grant/Award
38,950$26.8838,950(D)

View →

Jul 10, 2026Jul 14 8:22 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
10,000$3.79120,546(D)

View →

Jul 8, 2026Jul 10 8:10 PMRyan CohlheppDirector, President and COO
Option Exercise
18,750$3.7970,502(D)

View →

Jul 8, 2026Jul 10 8:10 PMIvan HyepChief Financial Officer
Option Exercise
12,500$3.7938,836(D)

View →

Jun 9, 2026Jun 10 8:43 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
19,475$20.5619,475(I)

View →

Jun 9, 2026Jun 10 8:35 PMChristopher BowdenDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:34 PMKate HavilandDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:34 PMKiran Mazumdar-ShawDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:33 PMScott M. RobertsonDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:33 PMMichael PowellDirector
Grant/Award
19,475$20.5619,475(D)

View →

Jun 9, 2026Jun 10 8:32 PMJake SimsonDirector
Grant/Award
19,475$20.5619,475(D)

View →

May 21, 2026May 26 9:48 PMIvan HyepChief Financial Officer
Option Exercise
9,200$3.7970,584(D)

View →

May 18, 2026May 20 8:07 PMClaire MazumdarDirector, Chief Executive Officer
Option Exercise
15,000$3.79146,107(D)

View →

May 15, 2026May 18 8:24 PMRyan CohlheppDirector, President and COO
Option Exercise
8,000$3.79101,334(D)

View →

May 8, 2026May 12 8:04 PMWilliam SchelmanChief Medical Officer
Grant/Award
85,000$22.5885,000(D)

View →

Page 1 of 3

Next →